Opus Point Partners Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-87,718
Closed -$4.71M 59
2017
Q4
$4.71M Hold
87,718
4.07% 7
2017
Q3
$5.36M Hold
87,718
4.81% 5
2017
Q2
$5.36M Hold
87,718
4.91% 2
2017
Q1
$5.32M Hold
87,718
3.95% 3
2016
Q4
$4.93M Hold
87,718
3.93% 5
2016
Q3
$5.22M Hold
87,718
2.93% 5
2016
Q2
$4.82M Sell
87,718
-6,602
-7% -$351K 4.66% 3
2016
Q1
$4.76M Hold
94,320
3.68% 5
2015
Q4
$4.75M Buy
94,320
+51,352
+120% +$2.59M 3.14% 13
2015
Q3
$2.02M Buy
+42,968
New +$2.28M 1.12% 25

Other funds holding MRK

Opus Point Partners Management's MRK Position: Q1 2018 in Review

Opus Point Partners Management sold out of Merck (MRK) in Q1 2018, closing a stake of 87,718 shares — an estimated $4.71M sold.

Opus Point Partners Management first reported a position in MRK in Q3 2015 and held it in 10 quarters. The position peaked at $5.36M in Q2 2017. 1,993 funds tracked by Wall St. Rank hold MRK as of Q1 2018.

  • Opus Point Partners Management reported no remaining Merck position as of Q1 2018 after selling out during the quarter.
  • Opus Point Partners Management sold 87,718 Merck shares in Q1 2018, an estimated $4.71M.
  • Opus Point Partners Management first reported a position in Merck in Q3 2015 and held it in 10 quarters.
  • Opus Point Partners Management's Merck position peaked at $5.36M in Q2 2017.
  • 1,993 funds tracked by Wall St. Rank held Merck as of Q1 2018.

Based on Opus Point Partners Management's 13F filing for Q1 2018, filed 15 May 2018.